Search Results - "Burton, J.R"

Routine Endomyocardial Biopsies Beyond the First Year Have Low Diagnostic Utility in Heart Transplant Recipients by Fattah, I.A, Pearson, G.J, Tymchak, W.J, Burton, J.R, Chan, M, Lalonde, L, Kim, D.H

Get full text

P0814 : Hepatic improvement in response to ledipasvir/sofosbuvir/ribavirin as measured by the hepquant® (HQ)-shunt test in liver transplant (LT) recipients with allograft fibrosis or cirrhosis and non-LT patients with decompensated cirrhosis by Burton, J.R, O’Leary, J.G, Helmke, S, Herman, A, Cookson, M, Lauriski, S, Trotter, J.F, Denning, J, Pang, P, McHutchison, J, Curry, M.P, Everson, G.T

Get full text

A gas-accepting ion source for Accelerator Mass Spectrometry: Progress and applications by Roberts, M.L., von Reden, K.F., Burton, J.R., McIntyre, C.P., Beaupré, S.R.

“…The National Ocean Sciences Accelerator Mass Spectrometry (NOSAMS) facility at the Woods Hole Oceanographic Institution has developed an Accelerator Mass…”
Get full text

23 A MULTICENTER STUDY OF PROTEASE INHIBITOR-TRIPLE THERAPY IN HCV-INFECTED LIVER TRANSPLANT RECIPIENTS: REPORT FROM THE CRUSH-C GROUP by Verna, E.C, Burton, J.R, O'Leary, J.G, Lai, J.C, Saxena, V, Dodge, J.L, Everson, G.T, Trotter, J.F, Stravitz, R.T, Brown, R.S, Terrault, N.A

Get full text

Medullary thyroid cancer and pseudocirrhosis: case report and literature review by Harry, B L, Smith, M L, Burton, Jr, J R, Dasari, A, Eckhardt, S G, Diamond, J R

“…Pseudocirrhosis is a rare form of liver disease that can cause clinical symptoms and radiographic signs of cirrhosis; however, its histologic features suggest…”
Get full text

Progress with a gas-accepting ion source for Accelerator Mass Spectrometry by Roberts, M.L., von Reden, K.F., McIntyre, C.P., Burton, J.R.

“…The National Ocean Sciences AMS (NOSAMS) facility at Woods Hole Oceanographic Institution has developed a novel, gas-accepting microwave-plasma ion-source. The…”
Get full text

First experience with direct, selective factor Xa inhibition in patients with non‐ST‐elevation acute coronary syndromes: results of the XaNADU‐ACS Trial by ALEXANDER, J. H., YANG, H., BECKER, R. C., KODAMA, K., GOODMAN, S., DYKE, C. K., KLEIMAN, N. S., HOCHMAN, J. S., BERGER, P. B., COHEN, E. A., LINCOFF, A. M., BURTON, J. R., BOVILL, E. G., KAWAI, C., ARMSTRONG, P. W., HARRINGTON, R. A.

“…Background: Unfractionated heparin is widely used in patients with non‐ST‐elevation acute coronary syndromes but has important limitations. Anticoagulants with…”
Get full text

Initial experience with factor‐Xa inhibition in percutaneous coronary intervention: the XaNADU‐PCI Pilot by Alexander, J. H., Dyke, C. K., Yang, H., Becker, R. C., Hasselblad, V., Zillman, L. A., Kleiman, N. S., Hochman, J. S., Berger, P. B., Cohen, E. A., Lincoff, A. M., Saint‐Jacques, H., Chetcuti, S., Burton, J. R., Buergler, J. M., Spence, F. P., Shimoto, Y., Robertson, T. L., Kunitada, S., Bovill, E. G., Armstrong, P. W., Harrington, R. A.

“…Background: Direct factor (F)Xa inhibition is an attractive method to limit thrombotic complications during percutaneous coronary intervention (PCI)…”
Get full text

Consumer Representation and Local Telephone Rates by MAYER, ROBERT N., ZICK, CATHLEEN D., BURTON, JOHN R.

“…The study reported here attempts to determine the impact of several political factors, including the type of proxy advocacy provided by state government, on…”
Get full text

LAND USE AND FLOOD RISK THROUGH CATCHMENT FLOOD-MANAGEMENT PLANS by Burton, A. J. R., Shepard, M. A., Riddell, K. J.

“…ABSTRACT Catchment Flood Management Plans involve a high‐level assessment of current flood risk and attempt to demonstrate how this risk could change with…”
Get full text